Graft-vs.-Host Disease Ruxolitinib for Graft-Versus-Host Disease Prophylaxis Following Tacrolimus Toxicity: A Case Series
Genitourinary Cancers Radiopharmaceuticals for Treatment of Metastatic Castration-Resistant Prostate Cancer